Best Life Sciences Companies in Brooklyn, United States
The 50 best Life Sciences companies in Brooklyn, United States in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Opentrons.
Our analysis of 164 Life Sciences companies
$34.7b in tracked funding; 83% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Life Sciences companies in Brooklyn
| # | Company | Disclosed funding | Last round | Employees | Founder | Stage | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|
| 1 | Opentrons 🦄 Developer of pipetting robot for lab automation 84Funding top 18%Market top 26%Moat top 26%Growth top 31% All 8 signals ▾Fundingtop 18% Markettop 26% Moattop 26% Growthtop 31% Techtop 32% Globaltop 37% Talenttop 38% Newstop 44% Funding: Raised $241M across 6 rounds · 6 rounds over 12 yrs (0.5/yr) Market: 177 employees (top 6% of Life Sciences Platforms and Tools) · Top-1,000,000 web property rank vs industry peers · Fliar Intelligence Index 84/100 | $241M | 8 mo ago | 177 177 → 196 (+11%) | James Atwood CEO | Series C | — | 3 launchs |
| 2 | Synchron Developer of implantable bioelectronics for the treatment of neurological conditions 48Funding top 17%News top 30%Talent top 38%Growth top 47% All 8 signals ▾Fundingtop 17% Newstop 30% Talenttop 38% Growthtop 47% Moattop 48% Marketbottom 46% Globalbottom 39% Techbottom 35% Funding: Raised $145M across 6 rounds · 6 rounds over 5 yrs (1.2/yr) News: 3 BI events in 12 mo (of 14 tracked, 7 types) · Top themes: Funding, Capital raise rank vs industry peers · Fliar Intelligence Index 48/100 | $145M | 9 mo ago | 53 53 → 130 (+145%) | Rahul Sharma Co-Founder | Series D | — | 2 job openings |
| 3 | Nanotronics Provider of an automated vision-based inspection system | $136M | 50 mo ago | 94 | Matthew Putman Founder & CEO | Series E | 5 patents Computational imaging and affinity-driven self-assembly of photonic/electronic devices. | — |
| 4 | Variant Bio Developer of therapeutics for the treatment of orphan indications | $128M | 56 mo ago | 50 | Stephane Castel Co-Founder | Series B | — | — |
| 5 | Accutar Biotechnology Provider of artificial intelligence-based solutions for accelerating drug discovery and development processes | $91M | 64 mo ago | 37 | Jie Fan Founder & CEO | Series C | 145 patents Design of small‑molecule kinase degraders and computational docking for oncology drugs | — |
| 6 | Epibone Developer of patient‑specific bone and cartilage grafts 50Moat top 25%Talent top 28%Funding top 29%Patents top 32% All 9 signals ▾Moattop 25% Talenttop 28% Fundingtop 29% Patentstop 32% Innovationtop 38% Techtop 46% Globalbottom 42% Marketbottom 31% Newsbottom 21% Moat: Editorial + unicorn rating 7/10 · IP moat: 48 patents Talent: 4 named leaders on record · 4 C-suite/founder profiles curated rank vs industry peers · Fliar Intelligence Index 50/100 | $44M | 11 mo ago | 34 | Elisa Cimetta Co-Founder | Series B | 48 patents Regenerative orthopedic biomaterials: injectable off‑the‑shelf cartilage/tendon/ligament scaffolds and decellularized bone matrice | — |
| 7 | HistoWiz We are hiring: https://histowiz.workable.com/ About HistoWiz HistoWiz is an innovative company dedicated to… | $34M | 57 mo ago | 85 | — | Series A | 8 patents AI-powered automated tagging and quality control for digital histology slide images | — |
| 8 | Kinnos Developer of real-time color visualizing bleach-based disinfectant | $32M | 39 mo ago | 13 13 → 9 (-31%) | Katherine Jin Co-Founder and CTO | Series A | 85 patents Antimicrobial surface decontamination formulations and stabilized colorant additives for cleaning products | — |
| 9 | CHF Solutions Ultrafiltration devices to treat fluid overload | $23M | 258 mo ago | 50 | — | Acqui-Hired | 84 patents Neonatal/paediatric extracorporeal blood filtration and cardiac assist device technologies | — |
| 10 | Datacubed Provider of solutions for patient engagement and data management in clinical trails | $22M | 42 mo ago | 64 | Paul Glimcher Founder & Chief Scientific Officer | Series A | — | — |
| 11 | Auxilius Online platform for clinical trial finance management | $20M | 30 mo ago | 30 | — | Series A | — | — |
| 12 | Biotia Provider of sequencing-based solutions for hospitals | $10M | 47 mo ago | 17 | Christopher Mason Co-Founder | Series A | — | 1 award |
| 13 | Phoenix Nest Biotech pioneering treatments for Sanfilippo Syndrome, an ultra-rare genetic disease | $9M | 25 mo ago | 11 | — | Funding Raised | — | — |
| 14 | nemedio Provider of a quality management software for healthcare professionals | $9M | 33 mo ago | 9 | Sabrina Varanelli Founder & CEO | Series A | 2 patents Dynamic configuration software for external hardware devices | — |
| 15 | Innovimmune Innovating immunotherapies for cancer, autoimmune diseases, and chronic inflammation | $7M | 169 mo ago | — | Anderson Gaweco President & CEO | Funding Raised | — | — |
| 16 | Melonfrost Operator of an online platform providing various casino-style games | $7M | 42 mo ago | 13 | Luc Harrigan Co-Founder | Deadpooled | 10 patents Advanced bioreactor hardware and AI-driven control of microbial evolution | — |
| 17 | Dadi Provider of sperm storage and analysis services | $7M | 84 mo ago | 48 | — | Acquired | 3 patents Medical sample collection and preservation devices for bodily fluids | — |
| 18 | Argon AI AI-powered insights and workflow automation for the pharmaceutical, biotech, and life sciences industries | $6M | 13 mo ago | — | Samy Danesh Co-Founder & CEO | Seed | 20 patents Inflatable cushioning pads and gas‑filled insulating foams; GNSS multipath interference mitigation systems. | — |
| 19 | Caladan Bio Developer of bioreactors for biotechnology research | $5M | 30 mo ago | — | Rob Jauquet Co-Founder | Seed | — | — |
| 20 | RegenLab Provider of medical devices to develop cellular therapies | $5M | 13 mo ago | 76 | Giuseppe Calloni CEO | Funding Raised | — | — |
| 21 | Neurosity Provider of neural devices and apps for mental health diagnosis and medical intervention | $5M | 46 mo ago | 5 | Alex Castillo CTO & Co-founder | Series A | 3 patents Brain‑computer interface headwear enabling direct computer control | — |
| 22 | Cloud Provider of cloud-based remote cardiology vital signs monitoring devices and platforms 67Growth top 21%Innovation top 22%Patents top 23%Moat top 32% All 11 signals ▾Growthtop 21% Innovationtop 22% Patentstop 23% Moattop 32% Fundingtop 35% Fin. healthtop 38% Producttop 39% Techbottom 48% Globalbottom 46% Newsbottom 40% Marketbottom 37% Growth: Revenue +701% YoY · Fresh capital in last 24 mo Innovation: 85 patents (top 21% of patent-holders) · 23 filings since 2022 vs 14 in 2017-21 rank vs industry peers · Fliar Intelligence Index 67/100 | $3M | 4 mo ago | 55 | — | Public | 85 patents Cloud-based health monitoring, telemedicine data transmission, and AR biomedical analytics | — |
| 23 | Xylyx Bio Developer of regenerative materials | $2M | 25 mo ago | 10 | Gordana Novakovic Co-Founder | Funding Raised | — | — |
| 24 | Concarlo Developer of therapies for treating breast cancer | $1M | 72 mo ago | 7 | LisaMarie Casey Co-Founder | Seed | 9 patents BRK peptide inhibitors for therapeutic cancer applications | — |
| 25 | Protes Manufactures protein chips | $1M | 118 mo ago | 1 | — | Series A | — | — |
| 26 | We Are The New Farmers Internet first brand for spirulina based food products | $500K | 36 mo ago | 8 | Dan Bernstein Co-Founder | Seed | — | — |
| 27 | Hard Beverages Caffeinated low calorie non-alcoholic natural craft sparkling beverages | $358K | 105 mo ago | — | Ron Kliot Founder & CEO | Seed | — | — |
| 28 | Lucerna Developer of RNA-based research reagents | $315K | 170 mo ago | 4 | Karen Wu President | Funding Raised | — | — |
| 29 | CMP Scientific Full spectrum of mass spectrometry-based analytical solutions | $300K | 116 mo ago | 5 | — | Funding Raised | — | — |
| 30 | Loki Therapeutics Developer of immune-therapeutic solutions for the treatment of cancer diseases | $295K | 26 mo ago | 1 | — | Funding Raised | — | — |
| 31 | Calder Biosciences Developer of influenza vaccines | $275K | 34 mo ago | 7 | Christopher P Marshall Founder & CEO | Seed | 43 patents Stabilized RSV pre‑fusion F protein vaccine antigens for improved respiratory syncytial virus immunization | — |
Top 12 Life Sciences companies in Brooklyn
#1
Series C · Brooklyn, New York · founded 2013 · 177 employees$240.6Mraised▾
Developer of pipetting robot for lab automation. The company's product OT-2 personal pipetting robot uses manual micro-pipettes to transfer fluids and automates the repetitive benchwork associated with lab activities. It also has scalable hardware and software and is developed in an open-source manner.
- Nov 2025Series C$20.1M
- Sep 2021Series C$200M
- Aug 2020Series B$20.6M
- Nov 2019Seed$2.2M
#2
Series D · Brooklyn, New York · founded 2016 · 53 employees$145Mraised▾
Developer of implantable bioelectronics for the treatment of neurological conditions. The company offers a motor neuroprosthesis the Stentrode which helps paralyzed patients regain the ability to communicate. Also, provides endovascular neuromodulation minimally invasive device that stimulates brain or nerve activity for the treatment of Parkinson’s disease, epilepsy, depression, and others.
- Nov 2025Series D$200M
- Dec 2022Series C$75M
- Dec 2021Grant (prize money)$990K
- Aug 2021Grant (prize money)$10M
#3
Series B · Brooklyn, New York · founded 2013 · 34 employees$44.3Mraised▾
Developer of patient‑specific bone and cartilage grafts. The company is offering custom‑shaped, living bone grafts engineered from a patient’s adipose‑derived mesenchymal stem cells and a CT scan of the defect. These are intended for complex bone‑reconstruction cases such as facial, craniofacial, or other skeletal defects.
- Sep 2025Series B$4.3M
- Nov 2024Series B—
- Dec 2022Series B$18.5M
- Nov 2021Series B$1M
#4
Public · Brooklyn, New York · founded 2014 · 55 employees$3.1Mraised▾
Provider of cloud-based remote cardiology vital signs monitoring devices and platforms. Its product is a virtual medical device that records a pulse wave signal from the wrist uploads it to the cloud and derives the major vital signs. It lets physicians monitor the signs of patients remotely to manage their conditions and progress in treatment and medication.
- Mar 2026Post IPO$578.1K
- Apr 2024Post IPO$2.1M
- Dec 2023Post IPO$1.9M
- Jul 2023Post IPO$2.7M
#5
Seed · Brooklyn, New York · founded 2023$6Mraised▾
AI-powered insights and workflow automation for the pharmaceutical, biotech, and life sciences industries. It help life sciences companies to automate data-intensive workflows, including trial design, indication selection, competitive intelligence, and market landscaping.
- Jul 2025Seed$5.5M
- 2024Seed$500K
- May 2024Seed$5.5M
#6
Funding Raised · Brooklyn, New York · founded 2003 · 76 employees$5Mraised▾
Provider of medical devices to develop cellular therapies. The company's product Regenkit A-PRP and Regenkit A PRP plus uses the patient's blood and collects platelets after centrifuging. These platelets can be used for hard and soft tissue repair mechanisms. The other products include RegenKit ACP 3, RegenKit-ETM - 3, RegenKit-THT-3, and accessory products.
- Jun 2025Conventional Debt$5M
#7
Funding Raised · Brooklyn, New York · founded 2012 · 11 employees$9.2Mraised▾
Biotech pioneering treatments for Sanfilippo Syndrome, an ultra-rare genetic disease. Focused on developing therapies for this devastating condition, the company is dedicated to improving the lives of affected children and their families. They conduct natural history studies and preclinical research to advance potential treatments for various subtypes of Sanfilippo Syndrome. The company collaborates with academic labs and leverages funding to drive innovation in this challenging therapeutic area. Their commitment extends to providing patient and physician resources, fostering a supportive community, and raising awareness about Sanfilippo Syndrome. They are working towards creating a future where individuals affected by this disease can live fuller, healthier lives.
- Jul 2024Grant (prize money)$881.7K
- Sep 2022Grant (prize money)$3M
- Sep 2017Grant (prize money)$224.9K
- Jun 2016Grant (prize money)$1.5M
#8
Series E · Brooklyn, New York · founded 2009 · 94 employees$136.3Mraised▾
Developer of robotic industrial microscopic devices designed to improve industrial image inspection and analysis. The company's ML and AI-based devices leverage optical microscopy, 3D imaging, and computational super-resolution and offer automatic wafer handling, rapid scanning, defect reports, and wafer mosaicing, enabling aerospace, electronics, and pharmaceutical industries to accelerate the inspection of wafers and images while eliminating illusions.
#9
Series A · Brooklyn, New York · founded 2019 · 30 employees$20Mraised▾
Developer of a clinical trial financial management platform designed to help sponsors track contract terms, budgets, and milestones. The company augments manual clinical business operations and accounting processes with intuitive software that scales, enabling sponsors to take control over trial costs and clinical vendors, manage financial risk, and optimize spending in pursuit of trial targets.
#10
Series B · Brooklyn, New York · founded 2018 · 50 employees$127.7Mraised▾
Developer of therapeutics for the treatment of orphan indications. The company offers its platform for the detection of human genetic diversity and provides treatment solutions for rare diseases.
- Nov 2021Series B$105M
- Aug 2020Series A$6.1M
- Oct 2019Series A$16.6M
#11
Series A · Brooklyn, New York · founded 2014 · 13 employees$32.3Mraised▾
Developer of real-time color visualizing bleach-based disinfectant. It offers bright blue color bleach based disinfectant wipes to visualise coverage and the color fades over time without staining.
- May 2023Series A$15M
- Nov 2022Series A$4.5M
- Jan 2021Series A$5.5M
- Feb 2020Series A$6.3M
#12
Series C · Brooklyn, New York · founded 2015 · 37 employees$91.5Mraised▾
Provider of artificial intelligence-based solutions for accelerating drug discovery and development processes.
- Apr 2021Series C—
- Dec 2020Series C$28.5M
- Aug 2020Series B$20M
- Jul 2019Series B$28M
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Life Sciences coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Biotechnology is moving in the United States
A read on the academic research around Biotechnology — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 6,260 United States-affiliated papers.
- Harvard University209
- Cornell University177
- University of Tennessee at Chattanooga140
- Howard Hughes Medical Institute126
- Johns Hopkins University121
- Gene33→164
- Transcription (linguistics)11→79
- Antibody11→62
- Genome6→56
- Mutation7→56
- Gene8→110
- Cell culture3→62
- Gene expression3→62
- Fermentation2→54
- Downregulation and upregulation1→50
- Agriculture19→58
- Antibiotic resistance15→45
- Public health4→31
- Gene6→30
- Production (economics)5→29
Where biotechnology is researched across United States
Location clusters by institution affiliation — each city's volume, stance tone, and a quick read on its hot topic, what's advancing, the opening opportunity, and the main concern.
Who's filing biotechnology patents in the United States
United States biotechnology patent filing is accelerating — 457,918 filings from 8,000 assignees (2016–2025), led by Genentech, UNIV California, Regeneron Pharma; annual filings 36884→44446.
- Genentech18078
- UNIV California17948
- Regeneron Pharma16082
- Amgen10495
- Monsanto Technology9742
- UNIV Pennsylvania8521
- Harvard College7460
- UNIV Texas7378
Common questions
Riya reads income statements for fun. She covers the real money in a sector — revenue, growth, who actually earns — and never met a vague claim she didn't want a number for.